Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive drug treatment

J McCune1, N G Singer

  • 1Taubman Center, Ann Arbor, MI, USA.

Current Opinion in Rheumatology
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Immunosuppressive drugs are increasingly used for rheumatic diseases. This review covers individual agents, patient immunization, and managing communicable illness exposure in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.

Lupus·2014
Same author

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.

Annals of the rheumatic diseases·2012
Same author

Use of atorvastatin in systemic lupus erythematosus in children and adolescents.

Arthritis and rheumatism·2011
Same author

An informatics strategy for cancer care.

Biomedical imaging and intervention journal·2011
Same author

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.

Annals of the rheumatic diseases·2011
Same author

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.

Lupus·2010

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • The use of immunosuppressive agents in managing rheumatic diseases is growing.
  • Increased clinical experience necessitates updated literature reviews.

Purpose of the Study:

  • To review recent literature on individual immunosuppressive agents for rheumatic diseases.
  • To provide updated recommendations for immunizing immunosuppressed patients.
  • To discuss strategies for managing communicable illness exposure in this population.

Main Methods:

  • Literature review of recent reports on immunosuppressive drugs.
  • Synthesis of recommendations for patient immunization.
  • Analysis of data on communicable illness exposure risks.

Related Experiment Videos

Main Results:

  • Recent advancements in understanding individual immunosuppressive agents.
  • Updated guidelines for immunization protocols in immunosuppressed individuals.
  • Assessment of risks and management strategies for common infections.

Conclusions:

  • Continued research and updated guidelines are crucial for optimizing immunosuppressive therapy in rheumatic diseases.
  • Proactive management of infections and immunizations is essential for patient safety.